Data as of Oct 22
| +0.92 / +1.26%|
The 4 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 67.50, with a high estimate of 90.00 and a low estimate of 58.00. The median estimate represents a -8.56% decrease from the last price of 73.82.
The current consensus among 5 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.